Just to be confusing, this is a different patent from the one that prevented Apple importing watches into the US. That patent is still in effect, while the patent in the $634 million ruling is a patent that expired in 2022, covering “low power pulse oximeter features,”but which Apple has now been ruled to infringed until the patent expired in 2022.